Mangoceuticals, Inc.

Contributing Author

Recent Articles by Mangoceuticals, Inc.

Mar-06	Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds MGRX GlobeNewswire
Feb-23	Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study MGRX GlobeNewswire
Feb-19	MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program MGRX +48.83% MGRX GlobeNewswire
Dec-19	Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements MGRX -45.57% GlobeNewswire
Dec-19	Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy MGRX -45.57% GlobeNewswire
Dec-18	Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules MGRX +7.38% GlobeNewswire
Nov-13	Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs MGRX +24.37% GlobeNewswire
Nov-13	Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management MGRX -32.39% GlobeNewswire
May-27	Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu MGRX +11.83% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)